Business Context and Reporting Period
This Form 8-K Current Report was filed by Oracle Corporation on January 15, 2008. The filing addresses corporate governance changes, specifically the election of a new director to the Board of Directors.
Key Financial Metrics
The filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It discloses specific transactional values related to the new director's compensation and existing business relationships:
- Director Compensation: Annual retainer of $52,500; $3,000 per regular meeting; $2,000 per special meeting.
- Equity Grant: Initial stock option to purchase 60,000 shares of common stock, vesting 25% annually over four years. Future annual grants of 45,000 shares are scheduled commencing May 31, 2009.
- Related Party Transactions (Akamai Technologies):
- Oracle purchased approximately $145,000 in services from Akamai since the beginning of fiscal year 2007.
- Akamai purchased approximately $2,271,000 in software and services from Oracle since the beginning of fiscal year 2007.
- As of December 31, 2007, Oracle had contracted to provide approximately $444,000 of future services to Akamai.
Material Changes
The primary material change is the appointment of George H. Conrades to the Board of Directors on January 15, 2008. Mr. Conrades, previously the executive chairman of Akamai Technologies, Inc., will not initially join any board committees. The filing notes the existence of ongoing commercial transactions between Oracle and Akamai.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The primary risk disclosure relates to the potential for conflicts of interest due to the new director's prior executive role at Akamai, a company with which Oracle has existing commercial contracts. Mr. Conrades has entered into a standard indemnification agreement.
Investor Verification Checklist
- Verify the vesting schedule and exercise price of the 60,000-share stock option granted to George H. Conrades.
- Confirm the total value of outstanding contracts between Oracle and Akamai Technologies as of the filing date.
- Monitor future filings for any committee appointments for Mr. Conrades, which could trigger additional fees or equity grants.
- Review the Directors' Stock Plan terms to understand the valuation impact of future annual grants.